IMM27M

· ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMM27M, covering 2025-01-08 to 2025-01-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Solid Tumors [Phase 1]